Clincosm LogoSign in Get a demo

Carcinoma, Hepatocellular

Showing NaN - NaN of 39
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Carcinoma, Hepatocellular Trial in Worldwide (Brivanib, Placebo)

Terminated
  • Carcinoma, Hepatocellular
  • Hefei, Anhui, China
  • +31 more
Sep 23, 2015

Carcinoma, Hepatocellular, Marker, Biological Trial in Taipei

Not yet recruiting
  • Carcinoma, Hepatocellular
  • Marker, Biological
    • Taipei, Taiwan
      National Taiwn University Hospital
    May 14, 2015

    Carcinoma, Hepatocellular Trial in China, Korea, Republic of, Taiwan (Sorafenib (Nexavar, BAY43-9006), Placebo)

    Completed
    Has Results
    • Carcinoma, Hepatocellular
    • Sorafenib (Nexavar, BAY43-9006)
    • Placebo
    • Hefei, Anhui, China
    • +22 more
    Mar 26, 2014

    3T MRI to Predict TACE Response of HCC

    Unknown status
    • Carcinoma, Hepatocellular
      • Taipei, Taiwan
        National Taiwan Uinversity Hospital
      Feb 23, 2014

      Circulating Tumor Cells for Hepatocellular Carcinoma

      Unknown status
      • Carcinoma, Hepatocellular
      • Neoplasm Circulating Cells
        • Taipei, Taiwan
          National Taiwan University Hospital
        Nov 13, 2013

        Carcinoma, Hepatocellular Trial in Worldwide (BAY86-9766 MEK Inhibitor + Sorafenib)

        Completed
        • Carcinoma, Hepatocellular
        • BAY86-9766 MEK Inhibitor + Sorafenib
        • Shatin, New Territories, Hong Kong
        • +14 more
        Sep 5, 2013

        Carcinoma, Hepatocellular Trial in Worldwide (sunitinib malate, sorafenib)

        Terminated
        Has Results
        • Carcinoma, Hepatocellular
        • Fountain Valley, California
        • +170 more
        Dec 7, 2012

        Hepatocellular Carcinoma Non-resectable, Hepatocellular Carcinoma Recurrent, Carcinoma, Hepatocellular Trial in Worldwide

        Terminated
        • Hepatocellular Carcinoma Non-resectable
        • +12 more
        • Beverly Hills, California
        • +162 more
        Sep 7, 2012

        Carcinoma, Hepatocellular Trial in Taipei (Thalidomide(Thado))

        Terminated
        • Carcinoma, Hepatocellular
        • Taipei, Taiwan
          Taiwan Cooperative Oncology Group
        Oct 7, 2011

        Carcinoma, Hepatocellular Trial in Worldwide (Oxaliplatin + 5-Fluorouracil/Leucovorin, Doxorubicin)

        Completed
        • Carcinoma, Hepatocellular
        • Shanghai, China
        • +3 more
        Sep 17, 2010

        Carcinoma, Hepatocellular Trial in Taipei (Thalidomide(THADO), Tegafur/Uracil(UFUR))

        Unknown status
        • Carcinoma, Hepatocellular
        • Thalidomide(THADO), Tegafur/Uracil(UFUR)
        • Taipei, Ban-Ciao, Taiwan
          Far Eastern Memorial Hospital
        Feb 6, 2009

        Carcinoma, Hepatocellular Trial in Worldwide (Irinotecan plus capecitabine)

        Completed
        • Carcinoma, Hepatocellular
        • Irinotecan plus capecitabine
        • Shanghai, China
        • +8 more
        Apr 2, 2008

        Carcinoma, Hepatocellular, Liver Tumors Trial in Hong Kong, Singapore, Taiwan (Photodynamic therapy, Talaporfin Sodium)

        Completed
        • Carcinoma, Hepatocellular
        • Liver Neoplasms
        • Photodynamic therapy
        • Talaporfin Sodium
        • Hong Kong, Hong Kong
        • +8 more
        Dec 5, 2007

        IL-1 Gene Complex on Development of Chronic Hepatitis and

        Unknown status
        • Hepatitis B
        • +2 more
          • Taipei, Taiwan
            Department of Medical Genetics; National Taiwan University Hospi
          Mar 20, 2007